Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ondrej Hylse"'
Autor:
Yvona Brychtová, Alexandra Oltová, Pavel Vesely, Jan Verner, Martin Trbušek, Kristina Zaprazna, Pavlína Janovská, Jiri Kohoutek, Zuzana Jašková, Marek Borsky, Ondrej Hylse, Vitezslav Bryja, Kamil Paruch, Marta Dzimkova, Marie Kasparkova, Jana Zemanová, Jana Collakova
Publikováno v:
Oncotarget
Oncotarget. 2016, vol. 7, issue 38, p. 1-16.
Oncotarget. 2016, vol. 7, issue 38, p. 1-16.
// Jana Zemanova 1 , Ondrej Hylse 2, 3 , Jana Collakova 4, 5 , Pavel Vesely 5 , Alexandra Oltova 1 , Marek Borsky 1 , Kristina Zaprazna 6 , Marie Kasparkova 1 , Pavlina Janovska 7 , Jan Verner 1 , Jiri Kohoutek 8 , Marta Dzimkova 8 , Vitezslav Bryja
Publikováno v:
Tetrahedron Letters. 56:6171-6173
alpha-Hydroxy-beta-dicarbonyls are known to undergo base-induced rearrangement to alpha-acyloxy carbonyls by a mechanism believed to involve an oxirane C-C bond scission step. Herein, we report the first example of this process in a vinylogous system
Publikováno v:
ChemInform. 47
alpha-Hydroxy-beta-dicarbonyls are known to undergo base-induced rearrangement to alpha-acyloxy carbonyls by a mechanism believed to involve an oxirane C-C bond scission step. Herein, we report the first example of this process in a vinylogous system
Autor:
Marek Nečas, Mari Ytre‐Arne, Magnar Bjoraas, Lukáš Maier, Ondrej Hylse, Kamil Paruch, Bjoern Dalhus, Martin Trbušek
Publikováno v:
ChemInform. 45
Autor:
Ludmila Šebejová, Martin Trbušek, Ondrej Hylse, Šárka Pospíšilová, Šárka Pavlová, Kamil Paruch, Jiri Mayer, Jana Zemanová
Publikováno v:
Blood. 120:2460-2460
Abstract 2460 Mutations in the TP53 gene are usually associated with very poor prognosis in hematological malignancies, including strong resistance to therapy. The concept of synthetic lethality based on the inhibition of Chk1 kinase represents a pro
Autor:
Hana Paculová, Juraj Kramara, Šárka Šimečková, Radek Fedr, Karel Souček, Ondřej Hylse, Kamil Paruch, Marek Svoboda, Martin Mistrík, Jiří Kohoutek
Publikováno v:
Tumor Biology, Vol 39 (2017)
A broad spectrum of tumors develop resistance to classic chemotherapy, necessitating the discovery of new therapies. One successful strategy exploits the synthetic lethality between poly(ADP-ribose) polymerase 1/2 proteins and DNA damage response gen
Externí odkaz:
https://doaj.org/article/e7bcbdc4ad754e1e8d403ed31b65297e